UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Form 8-K
CURRENT
Pursuant to Section 13 of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 30, 2000
Meditech Pharmaceuticals, Inc.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
NEVADA 000-12561 95-3819300
--------------------------- ----------- ------------------
(State or other jurisdiction of (Commission (IRS employer
incorporation or organization) File No.) Identification no.)
PMB 382, 10105 E. Via Linda, #103, Scottsdale, AZ 85258
-----------------------------------------------------------------------
(Address of principal executive offices and zip code)
(480) 614-2874
------------------
(Registrant's telephone number)
<PAGE>
Item 5. Other Events
------------
Attached hereto as Exhibit 00.2 is a copy of Meditech Pharmaceutical, Inc.'s
press release dated July 6, 2000 titled "Meditech Pharmaceuticals, Inc. Secures
$30 Million Funding Commitment".
The agreement contains confidentiality provisions designed to safeguard the
confidential information to be shared by the parties under the agreement.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
-------------------------------------------------------------------
(c) Exhibits
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Meditech Pharmaceutical, Inc.'s press release dated July 6, 2000
titled "Meditech Pharmaceuticals, Inc. secures $30 Million Funding
Commitment:.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Signatures
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Meditech Pharmaceuticals, Inc.
(Registrant)
By: /s/ Gerald N. Kern
-------------------------
Gerald N. Kern
Chief Executive Officer
Date: July 5, 2000
